HOME >> BIOLOGY >> NEWS
Wistar immunologists awarded grants to promote the development of vaccinesagainst HIV-1 and human papilloma viruses

Philadelphia -- Three Wistar Institute immunologists have been awarded grants to support their development of vaccines against diseases that attack the mucous membranes. Principal Investigator, Hildegund Ertl, MD, was awarded a grant by the Mary L. Smith Charitable Lead Trust for her research on HIV-1 vaccines. Anthony Wlazlo, PhD, and Dariusz Kowalczyk, MD, researchers in Dr. Ertl's laboratory, earned fellowships from the Cancer Research Foundation of America for their development of vaccines against human papilloma viruses (HPV).

Because the mucous membranes are protected by an independent immune system, Dr. Ertl suspects they are not adequately protected by systemic vaccines. Consequently, she and her Wistar research team are designing vaccines that target the mucosal immune system.

To successfully prevent HIV-1, explains Dr. Ertl, a combination vaccine is needed to induce neutralizing antibodies at the site of virus entry, usually the genital mucosa, and to trigger the production of killer T cells. Immunologists have yet to determine if it is possible to do both simultaneously. The immune system typically generates either a Th1 response to disease, which activates killer T cells, or a Th2 response, which promotes the development of B cells that secrete antibodies at mucosal surfaces. It is a challenge, says Dr. Ertl, to develop a vaccine that can simultaneously induce both. Dr. Ertl's findings will also be useful to scientists in other research centers exploring similar approaches

At the same time, other scientists in Dr. Ertl's laboratory are developing vaccines against HPV, a group of viruses known to cause cervical cancer, the second most common malignancy in women. Rather than treating the cancer, explains Dr. Ertl, the key to controlling HPV is through a vaccine that prevents the infection. The researchers' goal is to produce a strong and enduring mucosal immunity by neutralizing antibodies that, in model systems, prevent infection
'"/>

Contact: Diana Cutshall
dcutshall@wistar.upenn.edu
215-898-3716
The Wistar Institute
6-Jul-1999


Page: 1 2

Related biology news :

1. Wistar-discovered antibody will help diagnose appendicitis
2. 2004 Wistar Institute Science Journalism Award winners announced
3. Call for Entries: The 2004 Wistar Institute Science Journalism Award
4. Wistar-developed antibody shows promise against brain tumors in Drexel trial
5. Wistar study offers new support for a histone code theory of gene regulation
6. Regeneration in the mammalian heart demonstrated by Wistar researchers
7. Wistar scientists add difficult-to-sequence stretches to human genome data
8. Wistar scientist receives award from National Cancer Institute
9. Director of Emory Vaccine Center to give Wistar Institutes 1999 Tadeusz J. Wiktor Memorial lecture
10. Wistar scientists find striking similarities between bacterial virus and human adenovirus
11. Wistar Institute scientists find key piece in gene regulation puzzle

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2019)... ... January 31, 2019 , ... ... Morrisville, NC, providing full, customizable clinical research services across multiple therapeutic areas, ... programs for early stage life science entrepreneurs in the Research Triangle region ...
(Date:1/25/2019)... (PRWEB) , ... January 24, 2019 , ... ... the results of its 2019 Association Industry Survey. The report indicates membership growth ... email between mid-November to early December 2018, received responses from over 500 association ...
(Date:1/20/2019)... (PRWEB) , ... January 16, 2019 , ... As the ... offering through the introduction of its own liver 3D cell culture models. In an ... its models, protocols and validation criteria so that any researcher can replicate these models ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 29, 2019 , ... K&R Negotiations announced today that Mladen Kresic, CEO ... event titled: Six Ways to Shorten the Sales Cycle : Reduce Complexity and ... the BrightTALK network. , Negotiation expert Kresic will discuss the realities of today’s ...
(Date:1/30/2019)... ... 30, 2019 , ... Through its Microbiome Grant Initiative ... study design, planning, sample collection, and analysis to a team of researchers at ... study the interactions between gut microbial composition and cardiovascular health risks, such as ...
(Date:1/24/2019)... ... January 22, 2019 , ... Controlled Contamination Services is pleased to announce three ... of these valuable new team members will support its growing operation across the US ... CCS scales its business. This addition will enable CCS to widen its reach and ...
(Date:1/24/2019)... SAN FRANCISCO (PRWEB) , ... January 23, 2019 ... ... the leader in microbial genomics, has awarded microbiome research support in study design, ... Indies (UWI), Faculty of Medical Sciences, St. Augustine Campus in Trinidad led by ...
Breaking Biology Technology:
Cached News: